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AbstrACt
Introduction Chronic obstructive pulmonary disease 
(COPD) is a progressive lung disease associated with 
breathlessness, inability to exercise, frequent infections, 
hospitalisation and reduced quality of life. Pulmonary 
rehabilitation (PR), providing supervised exercise and 
education, is an effective and cost-effective treatment 
for COPD but is significantly underused. Interventions to 
improve referral and uptake have been tested and some 
positive results reported. However, interventions are 
diverse and no clear recommendations for practice can 
be made. This study aims to understand the challenges to 
referral and uptake in primary care, where most referrals 
originate, and to develop a flexible toolkit of resources to 
support referral and uptake to PR in primary care in the 
UK.
Methods and analysis This is a mixed methods study 
informed by normalisation process theory and burden of 
treatment theory. In the first phase, general practitioners, 
practice nurses and PR providers will be invited to 
complete an online survey to inform a broad exploration 
of the topic areas. In phase 2 interviews and focus groups 
will be conducted with patients, healthcare professionals 
(HCP) in primary care, PR providers and commissioners to 
gain an in-depth understanding of the issues and needs. 
Toolkit development in phase 3 will draw together the 
learning from phases 1 and 2 and employ an iterative 
development process to build the toolkit jointly with 
patients and HCPs. It will be tested in primary care for 
usability and acceptability.
Ethics and dissemination The study has ethical 
and Health Research Authority approval (Research 
Ethics Committee reference number 17/EE/0136). It is 
registered with the International Standard Registered 
Clinical/Social Study Number (ISRCTN) registry (trial ID: 
ISRCTN20669629, assignment date 20 March 2018, trial 
start date 1 April 2016). Dissemination will be aimed at 
patients, carers/families, service providers, commissioners 
and national interest groups. Methods will include 
conferences, presentations, academic publications and 
plain English reports and will be supported by the British 
Lung Foundation.
trial registration number ISRCTN20669629 ; Pre-
results.
IntroduCtIon 
Chronic obstructive pulmonary disease 
(COPD) is a progressive lung disease asso-
ciated with breathlessness, inability to exer-
cise, frequent infections and hospitalisation. 
Approximately 1.2 million people were living 
with diagnosed COPD in England in 20121 
and annual direct healthcare costs of COPD 
in England have been estimated to increase 
from £1.50 billion in 2011 to £2.32 billion in 
strengths and limitations of this study
 ► The study explicitly uses normalisation process the-
ory to inform data collection methods, data analysis 
and toolkit development which will maximise poten-
tial for the toolkit to be successfully implemented 
in practice.
 ► Patients who are unable to communicate in English, 
Hindi or Urdu will be excluded from the study.
 ► Patients who have declined pulmonary rehabilitation 
may be challenging to engage and so we will work 
closely with primary care to recruit this group.
 ► An iterative design process enables rapid develop-
ment of the toolkit in a way that readily allows it to 
be refined and tailored to the needs of users and the 
overall system, resulting in a design of higher quality 
which is more likely to stand the test of time.
 ► Outputs from survey and qualitative data will sup-
port identification of design priorities at the start of 
development which will provide focus for the itera-
tive process.
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2030.2 Pulmonary rehabilitation (PR), providing super-
vised exercise and education, is an effective treatment for 
COPD that leads to clinically significant improvements in 
exercise capacity, symptoms and health-related quality of 
life in patients who experience disabling breathlessness.3 
PR also supports self-management skills4 and results in 
fewer and shorter hospital admissions5 and readmissions.6 
It is a cost-effective treatment7 recommended for patients 
who are functionally disabled by COPD.8
However, despite published guidelines,8 9 PR is signifi-
cantly underused. In England and Wales in 2013/2014 
the estimated prevalence of patients with COPD eligible 
for PR was 446 000 but only 68 000 referrals were received 
by PR programmes. Of those patients referred, 31% did 
not attend for assessment.10 There is an urgent need to 
review PR referral pathways, healthcare professional 
(HCP) training, information for patients and referrers, 
and barriers to patient access, particularly in primary care 
in England and Wales where 51% of referrals originate.10
Referral rates are impacted by a range of factors 
including difficult referral processes, lack of information 
about PR and unclear roles and responsibilities regarding 
referral.11–24 A recent systematic scoping review of barriers 
and enablers to PR referral identified the most common 
barriers to be low knowledge of, or disbelief in, the bene-
fits of PR and low knowledge of the referral process; other 
frequently identified barriers were low knowledge of the 
eligibility criteria, low awareness of PR and a belief that 
gaining behaviour change in reluctant patients would be 
too difficult.25 The same review reported that the most 
frequently identified enablers of PR referral were PR 
training, mentoring or experience in PR; other enablers 
were PR awareness events, reminders and a streamlined 
referral process. Uptake by patients is impacted by the 
quality of the HCP conversation about PR and patients’ 
beliefs about the benefits, as well as timing, location and 
transport.26–28
Interventions to improve referral and uptake have 
been reported29–42 and the results of these have been 
summarised in a systematic review.43 In this review, 4 out 
of 10 studies that measured referral reported statistically 
significant increases in referral: the interventions included 
a patient-held care quality scorecard,34 clinician educa-
tion35 41 and mandatory monitoring of quality indicators 
in a hospital setting.37 Two out of four studies measuring 
uptake reported statistically significant increases in 
uptake: a patient manual summarising evidence of COPD 
treatments39 and individualised care planning supported 
by nurses and general practitioners (GP).40 Most of the 
studies measured referral or uptake to PR in the context 
of multifaceted evidence-based management of COPD. 
Clear recommendations for practice could not be made 
due to the diverse range of study designs and most study 
designs carrying a high risk of bias.43
This paper presents the protocol for a mixed methods 
study to support the improvement of referral and uptake 
to PR from primary care. The study runs from April 2016 
to May 2019.
Aims and objectives
The aim is to understand the needs of HCPs and patients 
in general practice concerning the challenges to referral 
and uptake, and then use this understanding to develop 
a flexible toolkit of resources to support referral and 
uptake of PR within primary care.
The research questions are:
1. From HCPs and patients’ perspectives how can barri-
ers to PR referral and uptake be overcome and facilita-
tors of utilisation be supported?
2. What components do HCPs and patients believe 
should be included in a toolkit to increase PR referral 
and uptake?
3. How acceptable and useable is the toolkit for HCPs 
and patients as a means to increase referral and uptake 
of PR?
The objectives to address the research questions are:
A. Conduct empirical research to identify factors that 
HCPs and patients believe will overcome barriers and 
facilitate referral and uptake to PR in primary care.
B. Synthesise evidence from empirical research and our 
systematic literature review to develop the toolkit col-
laboratively with patients and providers.
C. Conduct usability and acceptability testing of the tool-
kit in a sample of primary care practices to assess per-
formance and gather data to provide a basis for future 
efficacy and economic analysis.
Guiding theory
The research design is informed by normalisation 
process theory,44 45 an established theoretical framework 
for understanding implementation processes through 
multiple stakeholder perspectives. Normalisation process 
theory will provide the theoretical underpinning for data 
collection, analysis and interpretation, and toolkit devel-
opment. The four key constructs of normalisation process 
theory will be applied to the PR context to understand 
how PR referral becomes embedded in clinical practice:
A. Coherence: how PR is understood by clinicians.
B. Cognitive participation: clinicians’ buy-in and support 
for PR.
C. Collective action: the operational work required for 
PR referral.
D. Reflexive monitoring: how PR is appraised by clini-
cians and how work is reconfigured to enable it to 
happen.
Closely aligned to normalisation process theory, 
burden of treatment theory will be used to understand 
patients’ experiences.46 This theory provides a structural 
model of the relationship between treatment burden and 
patients’/carers’ capacity to undertake work required 
to manage their condition, and helps to understand 
variations in healthcare utilisation and adherence.47 
Health service responses to reduce this burden will be 
understood through the minimally disruptive medicine 
model, a patient-centred approach in which patients 
and professionals work together to advance patient goals 
while imposing the smallest possible treatment burden.48 
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Key elements of burden of treatment theory and mini-
mally disruptive medicine mirror those of normalisation 
process theory and will inform understanding of how 
patients:
A. Make sense of their health conditions, tests and treat-
ments.
B. Enrol support, plan to attend healthcare visits and en-
act self-care activities.
C. Operationalise the work of attending visits and 
self-managing their care.
D. Monitor, appraise and evaluate the worth of the work 
they are doing.
MEthods And AnAlysIs
study overview
The study comprises three phases:
Phase 1: Online survey of HCPs in general practice and 
online survey of PR providers.
Phase 2: Qualitative research with patients, HCPs and 
commissioners.
Phase 3: Toolkit development research.
Figure 1 shows how the phases map to the research 
questions.
Phases 1 and 2 will address the topic areas listed below 
to identify facilitators and barriers to referral and uptake 
and explore current practice and ideas for improvement. 
The data collection and analysis during these phases will 
be informed by normalisation process theory in order to 
explicate how current ways of working, and the impact 
of barriers and facilitators, are embedded and sustained 
in practice. The application of normalisation process 
theory will also inform understanding of how ideas for 
improvement can be embedded and sustained. We will 
sample from four participant groups (patients, HCPs, PR 
providers and commissioners) in order to compare and 
contrast the perspectives and needs of these groups in 
relation to PR referral. The topic areas are:
 ► Influences on HCP decisions to refer to PR.
 ► Reasons why patients take up or decline a referral.
 ► Methods to make it easier to refer to PR and take up 
a referral.
 ► Tools/strategies in use to prompt referral and uptake.
 ► Support or training that would improve counselling 
of patients regarding PR.
 ► Ways to ensure effective communication between 
primary care and PR providers regarding referrals.
 ► Priorities and design considerations that the toolkit 
should address.
Findings from phases 1 and 2 will inform toolkit devel-
opment in phase 3. The final study output will be a toolkit 
tested in clinical practice for usability and acceptability 
which, if validated, will be ready for wider testing.
Phase 1: online surveys of hCPs in general practice and of Pr 
providers
The surveys enable a broad exploration of the topic areas. 
Pulmonary disease or long-term condition leads in all GP 
practices in the East of England (n=approximately 455) 
will be invited to complete the general practice survey by 
the Clinical Research Network Eastern. The study team 
will send invitations to all PR providers (n=21) in the 
East of England PR Network to complete the PR provider 
survey.
Survey design is informed by normalisation process 
theory and includes items adapted from the NoMAD 
tool.49 We sought input to the design from practice 
nurses and PR providers and piloted each survey. Items 
are dichotomous, multiple response or Likert scales, 
supplemented by free-text questions (see online supple-
mentary materials 1 and 2). We will invite HCPs to submit 
relevant resources that they recommend. Surveys will 
be implemented on the Online Surveys platform50 and 
a prize draw of £200 in online shopping vouchers will 
incentivise returns.
Quantitative data will be uploaded to SPSS (V.25) for 
descriptive analysis including frequencies and compar-
ison of responses by different healthcare providers 
and levels of experience. General practice data will be 
compared by Clinical Commissioning Group area and 
Figure 1 Mapping of research questions and phases. HCP, healthcare professional; PR, pulmonary rehabilitation. 
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mapped onto referral and uptake data from PR services 
where this is available.
Free-text responses will be imported into NVivo V.12 
software. Analysis will follow a ‘framework’ approach as 
described by Ritchie et al.51 Constructs from normalisation 
process theory will inform a deductive coding structure 
supplemented by inductive coding to allow unexpected 
findings to emerge. Codes will be grouped into categories 
and a working analytical framework developed which will 
be applied to all data. Data will be summarised by cate-
gory in framework matrices on which the final interpreta-
tion will be based.
Phase 2: qualitative research with patients, hCPs and 
commissioners
The purpose of the qualitative research is to enable an 
in-depth exploration of the topic areas with the following 
groups:
1. Patients who have accepted a PR referral (focus 
groups).
2. Patients who have declined a PR referral (interviews).
3. Patients who have not been referred to PR (interviews).
4. HCPs in primary care who refer patients to PR (inter-
views and/or focus groups).
5. Commissioners of PR services (interviews). National 
Health Service (NHS) commissioners are responsible 
for planning and purchasing healthcare services for 
their local populations.
6. Physiotherapists and/or nurses who deliver PR (focus 
group).
Inclusion criteria
Patients will be eligible if they are resident in the East of 
England, have a diagnosis of COPD with stable disease, 
are eligible for PR as defined by guideline recommen-
dations8 and able to read and write in English. Patients 
who have accepted a PR referral will be eligible if they 
have attended only one programme. In addition, we will 
conduct interviews and focus groups in two geographical 
areas specifically targeting patients of South Asian heri-
tage. For these activities, patients will be eligible if they 
do not have the ability to read or write in English but can 
communicate, read and write in Hindi or Urdu.
Sampling
We will begin by identifying four PR services within the 
East of England based on utilisation of commissioned 
places in 2014/2015. We will select the two services with 
the highest utilisation rates and the two with the lowest 
utilisation rates and then apply convenience sampling to 
identify participants as follows:
Patients and HCPs: Following convenience sampling 
within the PR services and the general practices that 
refer to them, we will recruit patients who have accepted 
a PR referral, patients who have declined or have not 
been referred to PR and HCPs in primary care who refer 
patients to PR. We will aim to achieve a gender balance 
among patients.
Commissioners: We will use convenience sampling to 
identify a commissioner of each of the four PR services.
PR providers: We will use convenience sampling within 
the East of England PR Network to identify PR providers 
across the region.
We will also select two geographical areas in the East of 
England that have populations of South Asian heritage. 
We will use convenience sampling within the PR services 
and general practices to identify patients of South Asian 
heritage who have accepted a PR referral, patients who 
have declined or have not been referred to PR and HCPs 
in primary care who refer patients to PR. We will aim for 
gender balance among patients.
We envisage that it may be challenging to recruit some 
participants, including patients who have declined PR 
and clinicians in primary care with busy and demanding 
schedules, and so convenience sampling will allow us flex-
ibility in achieving the required numbers of participants. 
To enhance validity, the final sample size will be deter-
mined by the need to reach data saturation. In a study 
of patients referred to PR, Arnold et al52 achieved satura-
tion with 24 patients. Table 1 shows an estimation of the 
sample sizes to be aimed for. If necessary, more partici-
pants will be sought in order to achieve data saturation 
or the final number may be lower if saturation is achieved 
with a lower number.
Focus groups have the benefit of drawing out shared 
experiences among participants and we have planned 
focus groups where we have a reasonable expectation 
of being able to convene sufficient numbers of partici-
pants. Where we do not expect this to be the case we have 
planned for interviews.
Recruitment
Patients who have accepted a PR referral: Each PR service 
will identify eligible patients, issue the invitation to attend 
the focus group and confirm attendance.
Patients who have declined a PR referral or who have 
not been referred to PR: General practices will identify 
Table 1 Estimated sample sizes for each group of 
participants
Participant group
Estimated 
sample size
Patients who have accepted a PR referral (six 
focus groups of up to eight participants)
Up to 48
Patients who have declined a PR referral 
(interviews)
Up to 9
Patients who have not been referred to PR 
(interviews)
Up to 9
HCPs in primary care who refer patients to 
PR (interviews and/or focus groups)
Up to 34
Commissioners of PR services (interviews) 4
Physiotherapists and/or nurses who deliver 
PR (focus group)
Up to 10
HCP, healthcare professional; PR, pulmonary rehabilitation. 
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patients from their COPD register and the invitation will 
be made by a clinician known to the patient. Telephone 
interviews, home visits or an interview on general prac-
tice premises will be offered to encourage participation. 
Interested patients will agree to be contacted by the study 
team who will make arrangements for interview.
HCPs in primary care: Clinical Research Network 
Eastern will invite HCPs to participate. Interested prac-
tices will return an expression of interest form to the Clin-
ical Research Network who will inform the study team. 
The team will then arrange the interview or focus group.
Commissioners of PR services: The study team will iden-
tify and invite commissioners with support from Clinical 
Research Network Eastern.
Physiotherapists/nurses who deliver PR: The study 
team will invite participation through the East of England 
PR network.
Informed consent
Study team researchers will take written informed consent 
prior to commencing interviews or focus groups. Where 
telephone interviews are conducted consent will be taken 
verbally and recorded on audio prior to the interview. 
Consent will also be taken from carers, family members or 
friends who accompany participants as they may provide 
information about the participant during the course of 
the interview or focus group. Participants will be free to 
withdraw from the study at any time.
Data collection
Question guides for interviews and focus groups 
(online supplementary materials 3–8) are developed 
from the relevant topic areas. Patient focus groups will 
be held at community or healthcare venues and inter-
views will be at the patient’s home, a healthcare venue or 
conducted by telephone. Focus groups in general prac-
tice may be challenging to organise due to competing 
work schedules and geographical location so we will offer 
one-to-one interviews as well, on general practice prem-
ises or by telephone. The PR provider focus group will be 
held at a healthcare venue and commissioner interviews 
at the commissioner’s place of work or by telephone. 
Interviews and focus groups will be audio recorded and 
transcribed verbatim.
Data analysis
Transcriptions and field notes will be imported into 
NVivo V.12 software for data management and analysis. 
Analysis will follow a ‘framework’ approach.51 Normal-
isation process theory constructs will inform a deduc-
tive coding structure supplemented by inductive coding 
to allow unexpected findings to emerge. Scripts will be 
read, re-read and coded by two researchers. Codes will 
be grouped into categories and a working analytical 
framework developed which will be applied to all tran-
scripts. Data will be summarised by category in framework 
matrices on which the final interpretation will be based.
Quality criteria
Structured and standardised question guides will ensure 
consistency. Transcripts will be coded independently by 
two researchers. Reviewing and revising the analysis with 
a patient reference group will provide a credibility and 
reliability check.
Phase 3: toolkit development research
The purpose of this phase is to synthesise findings from 
phases 1 and 2 and incorporate the learning into the 
toolkit development.
User group
A user group of up to fifteen HCPs and up to fifteen 
patients recruited from research participants, volun-
teers from patient and public involvement (PPI) events 
and British Lung Foundation networks will work with 
the study team, a web developer and an expert in design 
and development from the Engineering Design Centre 
at the University of Cambridge to develop the toolkit. 
We will offer a range of ways to participate in testing and 
feedback, for example, online, face-to-face meetings, 
visiting members, holding satellite meetings at profes-
sional conferences or service/training meetings. Written 
informed consent will be taken for all participants.
The design process
A rigorous, iterative design process (Explore, Create, 
Evaluate)53 (figure 2) will track the user journey from 
initial concept to building the toolkit, including the devel-
opment of criteria for acceptability and usability testing. 
To explore potential toolkit content and structure the 
needs, a review will take place of the summaries of themes 
identified from the survey and qualitative research. This 
will be underpinned by normalisation process theory 
and burden of treatment theory constructs, and will be 
supported further by the outputs from the literature 
review and work by other expert groups, for example, the 
British Thoracic Society PR Quality Improvement Group. 
A consensus method adapted from nominal group tech-
nique54 will be used to consider and vote on priorities. 
Content and media will be developed during the user-cen-
tred design process but we are aiming for a simple and 
practical toolkit with information about ways to impact 
referral and uptake. The toolkit is intended for direct use 
by HCPs in primary care with the aim of enhancing their 
understanding of PR, providing resources to support a 
meaningful and motivational conversation about PR with 
the patient and to facilitate the referral process. Exam-
ples could include key messages about the benefits of PR, 
electronic prompts/templates to prompt referral, links 
to guidelines and decision support tools and printing 
options. It is important that we do not pre-empt the 
design process, in terms of content or medium, as this 
must be coproduced with users. However, based on what 
we know from the literature about barriers to referral and 
uptake we would envisage important features to include: 
clear information about PR and its benefits and eligibility 
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criteria; prompts and tools to facilitate the referral 
process; tools to support an exploration of the patient’s 
needs and beliefs about PR; tools and information to 
support the HCP to motivate patients and encourage 
uptake. The toolkit may also include information for 
patients that can be shared with them by the HCP. It is 
not intended that patients will access the toolkit directly. 
Design will initially be solution neutral and will then be 
translated into practical solutions. Practical resource 
constraints will be considered and any user-defined needs 
that could not be addressed will be recorded. The group 
will also define initial assessment criteria for usability and 
acceptability testing.
Agile methods55 will be used to create the toolkit. The 
study team will build initial web pages in the live loca-
tion to develop concepts and stimulate ideas. Early and 
subsequent releases of the toolkit will be continuously 
explored, created, evaluated and fed back on with the 
user group, alongside continuous web development in 
short time cycles over 6 months. Usability and acceptability 
assessment criteria will determine the feedback requested 
and with each round of feedback the criteria will be open 
to further refinement as users explore and identify their 
practical needs. The toolkit will be built on a WordPress 
platform, a free open-source website infrastructure and 
content management system, and hosted on University 
of Cambridge web servers by University Information 
Systems. A web development expert from the University 
of Cambridge will lead the technical development. It will 
be designed to interface with working systems (in ways 
to be identified during the research, eg, linked through 
SystmOne,56 integrated into annual review) and a flexible 
design will enable ongoing development.
Data collection
During toolkit development subjective and objective 
data will be gathered from user group participants to 
assess the user-defined usability and acceptability criteria. 
The methods of testing acceptability and usability 
will be those best suited to measure those criteria. 
Therefore, at this stage, we cannot predetermine what 
those methods will be. However, we envisage considering 
a range of approaches including retrospective methods, 
for example, written feedback and interviews, and real-
time methods, for example, thinking aloud techniques 
and objective methods, for example, user observation. 
Testing will take place after each iteration of the design 
process.
Following development we will work with five general 
practices to identify the HCP most involved in PR refer-
rals and train them to use the toolkit for 4 weeks in a 
clinical setting. Feedback will be sought relating to the 
user-defined assessment criteria plus user experience, 
perceived understanding of PR and referral criteria, 
technical issues and nurse time to implement the toolkit. 
Each HCP will complete a short questionnaire following 
use of the toolkit with patients and an interview at the 
end of the 4-week period. Patients with whom the HCP 
has used the toolkit will complete a short evaluation ques-
tionnaire to assess the impact on the patient experience 
(online supplementary material 9). This will be returned 
directly to the study team with a stamped addressed enve-
lope. Questionnaires will reflect the evaluation criteria. 
Written informed consent will be taken from HCPs and 
patients. During this testing period, we will collect usage 
metrics from the system and data on referral numbers 
and uptake compared with baseline.
Data analysis
Quantitative data will be uploaded into Excel and 
descriptive analysis will be conducted to identify 
frequencies. Interviews will be audio recorded, tran-
scribed and uploaded to NVivo V.12 software for data 
management and analysis. Data analysis will follow 
procedures as described in phase 2 with the addition 
that the user-defined usability and acceptability criteria, 
together with normalisation process theory constructs, 
will inform the development of a deductive coding 
structure.
Figure 2 The fundamental questions of design are solved through successive cycles of exploring needs, creating concepts 
and evaluating options, guided by project management.51
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Patient and public involvement
We involved a range of people in PPI activities to inform 
the study design and plain English communications. Forty-
seven people from PR programmes and patient support 
groups attended across six meetings, we consulted four 
members of the Cambridge University Hospitals PPI 
panel and noted feedback from patient participants in 
meetings about the future of services throughout the 
Cambridgeshire and Peterborough healthcare system. A 
need for increased access to PR and the value of locating 
the study in primary care were seen as important. As a 
result we engaged a GP coapplicant to the study. PPI 
input is ongoing and we have established a PPI group, 
supported by a member of the study team, who will review 
research materials, feed back on the research analysis and 
support dissemination. We offer travel expenses to PPI 
meetings. The British Lung Foundation will also support 
active engagement of their patient members.
We also sought feedback on the research priorities 
from practice nurses at professional development meet-
ings. They wanted easy access to good quality information 
and methods to engage patients, and recommended an 
emphasis on patient benefit, rather than cost savings, to 
encourage practice nurses to participate.
EthICs And dIssEMInAtIon
The study has been given a favourable opinion by the 
Cambridge Central Research Ethics Committee (REC 
reference number 17/EE/0136) and has been granted 
approval by the Health Research Authority. It is registered 
with the ISRCTN registry (trial ID: ISRCTN20669629, 
assignment date 20 March 2018, trial start date 1 April 
2016).
The study involves minimal risks to patients; however, 
patients may be vulnerable due to age or frailty and the 
nature of COPD symptoms, including breathlessness 
and fatigue. Participants will be able to take breaks and 
terminate an activity if they are unable to continue. We 
will enquire about special support needs and participants 
can bring a friend or carer to any activity. Experienced 
researchers with appropriate training will undertake 
interviews and focus groups.
dissemination plan
We aim for timely dissemination, parallel to formal eval-
uation and clarifying how the outcomes will be of prac-
tical benefit to patients. Audiences include: patients 
and carers/families; HCPs who refer to PR and general 
practice managers; PR providers and service managers; 
PR commissioners; national interest groups, for example, 
British Thoracic Society; NHS England and NHS 
Improvement.
We will use a range of channels, working closely with the 
British Lung Foundation to use patient networks, publi-
cations, online information, service development and 
HCP engagement. We will use routes that are accessible 
to patient audiences, for example, Breathe Easy patient 
newsletters, INVOLVE website, posters in GP waiting 
rooms and PR classes, and village newsletters. PPI volun-
teers will disseminate to patient groups and networks.
Methods will include: presentations and written infor-
mation for HCP forums and professional networks; 
presentations at regional, national and international 
academic and professional conferences; open access 
academic papers in peer-reviewed journals; web and 
social media updates; written feedback to participants; 
broadcast and print media, for example, radio and news-
papers, may be considered if appropriate.
data deposition and curation
The study complies with the General Data Protection 
Regulation (2018). Data will be anonymised and entered 
onto secure NHS computers and University of Cambridge 
computers for data analysis. Signed paper consent forms 
containing participants’ names will be stored in a locked 
filing cabinet on NHS premises. Only the study team will 
have access to participants’ data. Electronic files will be 
password protected. Data sharing and storage will meet 
the requirements of the National Institutes of Health 
Research. Data will be securely stored in the University of 
Cambridge Research Repository.
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